Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function

1160.173.002 Boehringer Ingelheim Investigational Site, Hot Springs

1160.173.023 Boehringer Ingelheim Investigational Site, Fremont

1160.173.032 Boehringer Ingelheim Investigational Site, Moreno Valley

1160.173.034 Boehringer Ingelheim Investigational Site, Oceanside

1160.173.025 Boehringer Ingelheim Investigational Site, Salinas

1160.173.033 Boehringer Ingelheim Investigational Site, San Pedro

1160.173.024 Boehringer Ingelheim Investigational Site, Wilmington

1160.173.010 Boehringer Ingelheim Investigational Site, Washington D.C.

1160.173.020 Boehringer Ingelheim Investigational Site, Jacksonville

1160.173.036 Boehringer Ingelheim Investigational Site, Jacksonville

1160.173.012 Boehringer Ingelheim Investigational Site, Largo

1160.173.013 Boehringer Ingelheim Investigational Site, Tampa

1160.173.005 Boehringer Ingelheim Investigational Site, Columbus

1160.173.018 Boehringer Ingelheim Investigational Site, Springfield

1160.173.019 Boehringer Ingelheim Investigational Site, St Louis

1160.173.026 Boehringer Ingelheim Investigational Site, St Louis

1160.173.027 Boehringer Ingelheim Investigational Site, Neptune City

1160.173.014 Boehringer Ingelheim Investigational Site, Wilmington

1160.173.001 Boehringer Ingelheim Investigational Site, Altoona

1160.173.008 Boehringer Ingelheim Investigational Site, Pittsburgh

1160.173.037 Boehringer Ingelheim Investigational Site, Lancaster

1160.173.030 Boehringer Ingelheim Investigational Site, Memphis

1160.173.011 Boehringer Ingelheim Investigational Site, Fort Worth

1160.173.006 Boehringer Ingelheim Investigational Site, Live Oak

1160.173.021 Boehringer Ingelheim Investigational Site, Norfolk

1160.173.035 Boehringer Ingelheim Investigational Site, Waukesha